EUVIMED · CrossrefZeitschrift
Growth Hormone & IGF Research
ISSN 1096-6374 · Elsevier BV
Neueste Artikel
Real world performance of once weekly somatrogon on naive patients with isolated growth hormone deficiency: Mind the weight gain
Once-weekly somatrogon versus daily somatropin in pediatric growth hormone deficiency: A systematic review and meta-analysis
Age-specific reference intervals for IGF-I and IGFBP 3 in Indian adult males: Analytical comparison of IDS-iSYS and Roche immunoassays (INDIIGo II)
Achondroplasia: From bone to bench to bedside an integrated review of medical and surgical management strategies
Low IGF-1 combined with a single clonidine stimulation test as a confirmatory tool for pediatric growth hormone deficiency
Growth hormone receptor blockade in cancer treatment
Is Somatrogon different? 6-month clinical outcomes and follow-up data in Turkish children transitioned from Somatropin to Somatrogon
The growth plate: Zonal architecture, plasticity, and endocrine control of linear growth
The effect of methylphenidate on the dopamine and growth hormone response to exercise in children with attention-deficit hyperactivity disorder
Comparison of growth response and adverse reaction according to growth hormone dosing strategy for children with short stature: LG Growth Study
Biochemical discrepancies in the evaluation of the somatotroph axis: Elevated GH or IGF-1 levels do not always diagnose acromegaly
Effects of high-dose all-trans retinoic acid on longitudinal bone growth of young rats
Prevalence and predictors of abnormal glucose tolerance and its resolution in acromegaly: Single Centre retrospective study of 90 cases
Impact of short stature on quality of life: A systematic literature review
A single-center observational study assessing the predictive factors associated with the prognosis of acromegaly
Testing for growth hormone deficiency in children
Intermittent hypoxia suppression of growth hormone and insulin-like growth factor-I in the neonatal rat liver
IGFBP-4 and PAPP-A in normal physiology and disease
Growth hormone and insulin-like growth factor-I axis in type 1 diabetes
Two-year recombinant human growth hormone (rhGH) treatment is more effective in pre-pubertal compared to pubertal short children with X-linked hypophosphatemic rickets (XLHR)
Discrepancies in insulin-like growth factor signaling? No, not really
Early cessation and non-response are important and possibly related problems in growth hormone therapy: An OZGROW analysis
The growth hormone receptor
Fifty seven years of follow-up of the Israeli cohort of Laron Syndrome patients—From discovery to treatment
Growth hormone signaling pathways
Truncated somatostatin receptor 5 may modulate therapy response to somatostatin analogues — Observations in two patients with acromegaly and severe headache
Status of long-acting-growth hormone preparations — 2015
Hormonal and metabolic responses to repeated cycling sprints under different hypoxic conditions
Pregnancy-associated plasma protein-A expression in human breast cancer
Circadian variation in the pharmacokinetics of steady state continuous subcutaneous infusion of growth hormone in adult growth hormone deficient patients
EUVIMED